Latest Antipsychotic Stories
The Firm represents Risperdal lawsuit clients in claims that allege the antipsychotic medication caused men and boys to develop gynecomastia. Rockville Centre,
The Firm is representing a number of Risperdal lawsuit clients who allegedly developed gynecomastia (male breast growth) due to their use of the medication. New
Data Highlight Physician and Payer Receptivity to Emerging Agents for Treatment-Resistant Depression, According to Findings from Decision Resources Group BURLINGTON, Mass., June 23, 2014 /PRNewswire/
The San Diego personal injury lawyers of The Law Office of Melinda J. Helbock, A.P.C.
Takeda and Lundbeck to Present Late-breaker at International College of Neuropsychopharmacology World Congress VANCOUVER, British Columbia, June 16, 2014 /PRNewswire/ -- Takeda Pharmaceutical
The Firm is actively filing Risperdal lawsuits on behalf of men and young boys who allegedly developed gynecomastia, a condition categorized by male breast growth, after use of the antipsychotic.
Lack of Disease-Modifying Therapies is Expected to Remain a Critical Unmet Need and Provides Ample Opportunity for Developers, According to Findings from Decision Resources Group BURLINGTON,
The Firm is representing numerous boys and men in Risperdal lawsuits that allege use of the antipsychotic drug caused gynecomastia, or male breast growth. New
The law firm Schlichter, Bogard & Denton, LLP reports that it is investigating claims alleging that the atypical antipsychotic drug, Risperdal, is linked to serious injuries to boys and men.
The Firm is investigating Risperdal lawsuits on behalf of men and boys who allegedly developed gynecomastia due to their use of Risperdal. New York, New York